rheumatoid arthritis ra longterm autoimmune disorder primarily affects typically results warm swollen painful pain stiffness often worsen following commonly wrist hands involved joints typically involved sides disease may also affect parts body including skin eyes lungs heart nerves may result low red blood cell count inflammation around lungs inflammation around fever low energy may also often symptoms come gradually weeks cause rheumatoid arthritis clear believed involve combination genetic environmental underlying mechanism involves bodys immune system attacking results inflammation thickening joint also affects underlying bone diagnosis made mostly basis persons signs xrays laboratory testing may support diagnosis exclude diseases similar diseases may present similarly include systemic lupus erythematosus psoriatic arthritis fibromyalgia among goals treatment reduce pain decrease inflammation improve persons overall may helped balancing rest exercise use splints braces use assistive pain medications steroids nsaids frequently used help diseasemodifying antirheumatic drugs dmards hydroxychloroquine methotrexate may used try slow progression biological dmards may used disease respond however may greater rate adverse surgery repair replace fuse joints may help certain ra affects million people adults developed world per people newly developing condition onset frequent middle age women affected times frequently resulted deaths deaths first recognized description ra made dr augustin jacob landr√©beauvais term rheumatoid arthritis based greek watery inflamed ra primarily affects joints also affects organs associated problems include cardiovascular disease osteoporosis interstitial lung disease infection cancer feeling tired depression mental difficulties trouble arthritis joints involves inflammation synovial membrane joints become swollen tender warm stiffness limits movement time multiple joints affected polyarthritis commonly involved small joints hands feet cervical spine larger joints like shoulder knee also synovitis lead tethering tissue loss movement erosion joint surface causing deformity loss fibroblastlike synoviocytes fls highly specialized mesenchymal cells found synovial membrane active prominent role pathogenic processes rheumatic ra typically manifests signs inflammation affected joints swollen warm painful stiff particularly early morning waking following prolonged inactivity increased stiffness early morning often prominent feature disease typically lasts hour gentle movements may relieve symptoms early stages disease signs help distinguish rheumatoid noninflammatory problems joints osteoarthritis arthritis noninflammatory causes signs inflammation early morning stiffness less pain associated ra induced site inflammation classified nociceptive opposed joints often affected fairly symmetrical fashion although specific initial presentation may pathology progresses inflammatory activity leads tendon tethering erosion destruction joint surface impairs range movement leads deformity fingers may develop almost deformity depending joints involved specific deformities also occur osteoarthritis include ulnar deviation boutonniere deformity also buttonhole deformity flexion proximal interphalangeal joint extension distal interphalangeal joint hand swan neck deformity hyperextension proximal interphalangeal joint flexion distal interphalangeal joint zthumb zthumb zdeformity consists hyperextension interphalangeal joint fixed flexion subluxation metacarpophalangeal joint gives z appearance hammer toe deformity may seen worst case joints known arthritis mutilans due mutilating nature rheumatoid nodule sometimes skin common nonjoint feature occurs people type inflammatory reaction known pathologists necrotizing granuloma initial pathologic process nodule formation unknown may essentially synovitis since similar structural features occur nodule central area fibrinoid necrosis may fissured corresponds fibrinrich necrotic material found around affected synovial space surrounding necrosis layer palisading macrophages fibroblasts corresponding intimal layer synovium cuff connective tissue containing clusters lymphocytes plasma cells corresponding subintimal zone synovitis typical rheumatoid nodule may millimetres centimetres diameter usually found bony prominences elbow heel knuckles areas sustain repeated mechanical stress nodules associated positive rf rheumatoid factor titer acpa severe erosive arthritis rarely occur internal organs diverse sites several forms vasculitis occur ra mostly seen longstanding untreated disease common presentation due involvement small mediumsized vessels rheumatoid vasculitis thus commonly present skin ulceration vasculitic nerve infarction known mononeuritis rather rare skin associated symptoms include pyoderma gangrenosum sweets syndrome drug reactions erythema nodosum lobe panniculitis atrophy finger skin palmar erythema skin fragility often worsened corticosteroid usecitation needed diffuse alopecia areata diffuse aa occurs commonly people rheumatoid ra also seen often relatives lung fibrosis recognized complication rheumatoid arthritis also rare wellrecognized consequence therapy example methotrexate leflunomide caplans syndrome describes lung nodules individuals ra additional exposure coal dust exudative pleural effusions also associated people ra prone atherosclerosis risk myocardial infarction heart attack stroke markedly possible complications may arise include pericarditis endocarditis left ventricular failure valvulitis many people ra experience chest pain others feel angina myocardial infarction reduce cardiovascular risk crucial maintain optimal control inflammation caused ra may involved causing cardiovascular risk use exercise medications appropriately reduce cardiovascular risk factors blood lipids blood pressure doctors treat people ra sensitive cardiovascular risk prescribing antiinflammatory medications may want consider prescribing routine use low doses aspirin gastrointestinal effects anemia far common abnormality blood cells caused variety mechanisms chronic inflammation caused ra leads raised hepcidin levels leading anemia chronic disease iron poorly absorbed also sequestered macrophages red cells normal size color normocytic low white blood cell count usually occurs people feltys syndrome enlarged liver spleen mechanism neutropenia complex increased platelet count occurs inflammation role circadian clock rheumatoid arthritis suggests correlation early morning rise circulating levels proinflammatory cytokines painful morning joint renal amyloidosis occur consequence untreated chronic treatment penicillamine gold salts sodium aurothiomalate recognized causes membranous eye directly affected form scleritis severe rarely progress perforating scleromalacia rather common indirect effect keratoconjunctivitis sicca dryness eyes mouth caused lymphocyte infiltration lacrimal salivary glands severe dryness cornea lead keratitis loss vision well painful preventive treatment severe dryness measures nasolacrimal duct blockage liver problems people rheumatoid arthritis may due underlying disease process result medications used treat coexisting autoimmune liver disease primary biliary cirrhosis autoimmune hepatitis may also cause peripheral neuropathy mononeuritis multiplex may occur common problem carpal tunnel syndrome caused compression median nerve swelling around wrist rheumatoid disease spine lead myelopathy atlantoaxial subluxation occur owing erosion odontoid process andor transverse ligaments cervical spines connection skull erosion give rise vertebrae slipping one another compressing spinal cord clumsiness initially experienced without due care progress quadriplegia even constitutional symptoms including fatigue low grade fever malaise morning stiffness loss appetite loss weight common systemic manifestations seen people active ra local osteoporosis occurs ra around inflamed joints postulated partially caused inflammatory cytokines general osteoporosis probably contributed immobility systemic cytokine effects local cytokine release bone marrow corticosteroid incidence lymphoma increased although uncommon associated chronic inflammation treatment risk nonmelanoma skin cancer increased people ra compared general population association possibly due use immunosuppression agents treating periodontitis tooth loss common people rheumatoid ra systemic whole body autoimmune disease genetic environmental factors affect risk ra worldwide ra affects approximately adult population occurs one children studies show ra primarily affects individuals ages years seen commonly family history ra increases risk around three five times estimated genetics may account cases seropositive ra around seronegative ra strongly associated genes inherited tissue type major histocompatibility complex mhc antigen major genetic factor implicated relative importance varies across ethnic genomewide association studies examining singlenucleotide polymorphisms found around one hundred alleles associated ra risk alleles within hla particularly genes harbor risk hla encodes proteins control recognition self versus nonself molecules risk loci include genes affecting costimulatory immune example cytokine signaling lymphocyte receptor activation threshold eg innate immune less influence hla established epigenetic environmental risk factors smoking established risk factor ra caucasian populations increasing risk three times compared nonsmokers particularly men heavy smokers rheumatoid factor modest alcohol consumption may silica exposure linked infectious agent consistently linked ra evidence disease clustering indicate infectious periodontal disease consistently associated many negative findings suggest either trigger varies might fact chance event inherent immune ra primarily starts state persistent cellular activation leading autoimmunity immune complexes joints organs clinical manifestations disease primarily inflammation synovial membrane joint damage fibroblastlike synoviocytes play key role pathogenic three phases progression ra initiation phase due nonspecific inflammation amplification phase due cell activation chronic inflammatory phase tissue injury resulting cytokines tnfalpha factors allowing abnormal immune response initiated become permanent chronic factors genetic disorders change regulation adaptive immune genetic factors interact environmental risk factors ra cigarette smoking clearly defined risk environmental hormonal factors may explain higher risks women including onset childbirth hormonal medications possibility increased susceptibility negative feedback mechanisms normally maintain tolerance overtaken positive feedback mechanisms certain antigens igg fc bound rheumatoid factor citrullinated fibrinogen bound antibodies citrullinated peptides acpa protein antibody debate relative roles bcell produced immune complexes cell products inflammation ra continued years neither cell necessary site inflammation autoantibodies iggfc known rheumatoid factors acpa acpa specificity diagnosing autoimmune diseases people ra abnormally glycosylated antibodies believed promote joint needed generalized abnormal immune response become established may take several years symptoms occur plasma cells derived b lymphocytes produce rheumatoid factors acpa igg igm classes large quantities activate macrophages fc receptor complement binding part intense inflammation binding autoreactive antibody fc receptors mediated antibodys nglycans altered promote inflammation people needed contributes local inflammation joint specifically synovium edema vasodilation entry activated tcells mainly microscopically nodular aggregates microscopically diffuse synovial macrophages dendritic cells function antigenpresenting cells expressing mhc class ii molecules establishes immune reaction disease progresses forming granulation tissue edges synovial lining pannus extensive angiogenesis enzymes causing tissue fibroblastlike synoviocytes prominent role pathogenic synovium thickens cartilage underlying bone disintegrate joint deteriorates raised calprotectin levels serving biomarker importantly inflammatory events limited synovium appear systemic evidence suggest alterations helper profile favoring inflammation inflammatory producing helper cells pathogenic cells come memory effector compartment ra patients peripheral cytokines chemokines attract accumulate immune cells ie activated b cells monocytes macrophages activated fibroblastlike synoviocytes joint space signalling rankl rank eventually trigger osteoclast production degrades bone needed fibroblastlike synoviocytes present synovium rheumatoid arthritis display altered phenotype compared cells present normal tissues aggressive phenotype fibroblastlike synoviocytes rheumatoid arthritis effect cells microenvironment joint summarized hallmarks distinguish healthy fibroblastlike synoviocytes hallmark features fibroblastlike synoviocytes rheumatoid arthritis divided seven cellintrinsic hallmarks four cellextrinsic cellintrinsic hallmarks reduced apoptosis impaired contact inhibition increased migratory invasive potential changed epigenetic landscape temporal spatial heterogeneity genomic instability mutations reprogrammed cellular metabolism cellextrinsic hallmarks fls ra promotes osteoclastogenesis bone erosion contributes cartilage degradation induces synovial angiogenesis recruits stimulates immune xrays hands feet generally performed many joints affected ra may changes early stages disease xray may show osteopenia near joint soft tissue swelling smaller normal joint space disease advances may bony erosions subluxation medical imaging techniques magnetic resonance imaging mri ultrasound also used technical advances ultrasonography like highfrequency transducers mhz higher improved spatial resolution ultrasound images depicting erosions conventional radiography color doppler power doppler ultrasound useful assessing degree synovial inflammation show vascular signals active synovitis important since early stages ra synovium primarily affected synovitis seems best predictive marker future joint ra clinically suspected physician may test rheumatoid factor rf anticitrullinated protein antibodies acpas measured anticcp needed test positive approximately twothirds time negative rf ccp antibody rule ra rather arthritis called seronegative occurs approximately third people first year illness rheumatoid factor likely negative individuals becoming seropositive time rf nonspecific antibody seen healthy people many chronic infections like hepatitis c chronic autoimmune diseases sj√∂grens syndrome systemic lupus erythematosus therefore test specific hence new serological tests check anticitrullinated protein antibodies acpas tests positive ra cases specificity around rf acpas many times present symptoms far common clinical test acpas anticyclic citrullinated peptide anti ccp elisa serological pointofcare test early detection ra combined detection rf antimcv sensitivity specificity source improve diagnostic capture rate early detection patients ra risk stratify individuals rheumatology field continues seek complementary markers rf anticcp ywhah one marker complements rf anticcp along serological measures like creactive protein systematic review described welcome addition rheumatology field authors indicate serum based marker additive armamentarium existing tools available clinicians adequate clinical evidence support clinical blood tests usually done differentiate causes arthritis like erythrocyte sedimentation rate esr creactive protein full blood count kidney function liver enzymes immunological tests eg antinuclear antibodyana performed stage elevated ferritin levels reveal hemochromatosis mimic ra sign stills disease seronegative usually juvenile variant rheumatoid acr eular rheumatoid arthritis classification criteria new criteria diagnostic criteria classification criteria identify disease high likelihood developing chronic however score greater unequivocally classifies person diagnosis rheumatoid arthritiscitation needed new classification criteria overruled old acr criteria adapted early ra diagnosis new classification criteria jointly published american college rheumatology acr european league rheumatism eular establish point value four areas covered new criteria accommodate growing understanding ra improvements diagnosing ra disease treatment new criteria serology autoimmune diagnostics carries major weight acpa detection appropriate diagnose disease early state joints destructions occur destruction joints viewed radiological images significant point acr criteria criterion longer regarded relevant type damage treatment meant avoid several medical conditions resemble ra need distinguished time rarer causes usually behave differently may cause joint sometimes arthritis undifferentiated stage ie none criteria positive even synovitis witnessed assessed ultrasound imaging rheumatoid arthritis ra specific classification ra european league rheumatism signs illness factors contributing difficulttotreat disease genetic factors microrna associated difficult treat rheumatoid arthritis gene polymorphisms seem correlated response biologic modifying antirheumatic drugs bdmards next one gene region reported associated worst disorder minor allele summon differential response monocytes ra patients provide increase proinflammatory cytokines including tnfŒ± possible gene polymorphism genes correlated response tnf gene part family genes called human leukocyte antigen hla complex hla complex human version major histocompatibility complex mhc currently identified least different versions presence alleles seems predict radiographic damage may partially mediated acpa development also elevated sera inflammatory levels high swollen joint count encoded risk allele share conserved sequence correlated development anticitrullinated protein gene strong correlation disease development susceptibility outcome rheumatoid arthritis ra may associate particular hladr alleles alleles vary among ethnic groups geographic micrornas factor development type disease micrornas usually operate negative regulator expression target proteins increased concentration biologic treatment bdmards antirheumatic drugs level mirna antitnfadmrads combination therapy potential novel biomarkers predicting monitoring outcome instance found significantly upregulated antitnfadmrads combination therapy example curious fact responder patients showed increase mirnas therapy paralleled reduction tnfŒ± interleukin rheumatoid factor rf creactive protein many tools used monitor remission rheumatoid arthritis e n w ln e r displaystyle sqrt sqrt sa disease activity affected person classified always reliable indicator treatment one major limitation lowgrade synovitis may cure ra treatments improve symptoms slow progress disease diseasemodifying treatment best results started early results recent systematic review found combination therapy tumor necrosis factor tnf nontnf biologics plus methotrexate mtx resulted improved disease control disease activity score dasdefined remission functional capacity compared single treatment either methotrexate biologic goals treatment minimize symptoms pain swelling prevent bone deformity example bone erosions visible xrays maintain daytoday primarily addressed diseasemodifying antirheumatic drugs dmards dosed physical activity analgesics physical therapy may used help manage ra generally treated least one specific antirheumatic combination therapies corticosteroids common use benzodiazepines diazepam treat pain recommended appear help associated regular exercise recommended safe useful maintain muscle strength overall physical physical activity beneficial people rheumatoid arthritis experience although little evidence suggest exercise may impact physical function long term study found carefully dosed exercise shown significant improvements patients physical activity increases production synovial fluid lubricates joints reduces moderate effects found aerobic exercises resistance training cardiovascular fitness muscle strength ra furthermore physical activity detrimental side effects like increased disease activity exercise uncertain eating avoiding specific foods specific dietary measures help improve occupational therapy positive role play improving functional ability people rheumatoid weak evidence supports use wax baths thermotherapy treat arthritis educational approaches inform people tools strategies available help cope rheumatoid arthritis may improve persons psychological status level depression use extradepth shoes molded insoles may reduce pain weightbearing activities insoles may also prevent progression diseasemodifying antirheumatic drugs dmards primary treatment diverse collection drugs grouped use convention found improve symptoms decrease joint damage improve overall functional dmards started early disease result disease remission approximately half people improved outcomes following drugs considered dmards methotrexate sulfasalazine leflunomide hydroxychloroquine tnf inhibitors certolizumab adalimumab infliximab etanercept abatacept anakinra auranofin additionally rituximab tocilizumab monoclonal antibodies also use tocilizumab associated risk increased cholesterol commonly used agent methotrexate frequently used agents including sulfasalazine leflunomide effective used months similar effectiveness methotrexate used sulfasalazine also appears effective shortterm treatment rheumatoid hydroxychloroquine addition low toxicity profile considered effective treatment moderate ra agents may used combination however people may experience greater side methotrexate important useful dmard usually first combined approach methotrexate biologics improves haq scores ra remission benefit combination methotrexate biologics occurs combination initial treatment drugs prescribed sequential stepup triple therapy consisting methotrexate sulfasalazine hydroxychloroquine may also effectively control disease adverse effects monitored regularly toxicity including gastrointestinal hematologic pulmonary side effects nausea vomiting abdominal pain reduced taking folic rituximab combined methotrexate appears effective improving symptoms compared methotrexate rituximab works decreasing levels bcells immune cell involved inflammation people taking rituximab improved pain function reduced disease activity reduced joint damage based xray images months people improvement symptoms using rituximab biological agents generally used methotrexate conventional agents effective trial three associated higher rate serious infections compared biological dmard agents used treat rheumatoid arthritis include tumor necrosis factor alpha inhibitors tnf inhibitors infliximab interleukin blockers anakinra monoclonal antibodies b cells rituximab interleukin blockers tocilizumab cell costimulation blockers abatacept often used combination either methotrexate biologic monotherapy tofacitinib methotrexate may improve ra remission rates abatacept used time well controlled low disease activity tnf inhibitors decreasing dose appear affect overall discontinuation tnf inhibitors opposed gradually lowering dose people low disease activity may lead increased disease activity may affect remission damage visible xray persons people screened latent tuberculosis starting tnf inhibitor therapy avoid reactivation tnf inhibitors methotrexate appear similar effectiveness used alone better results obtained used together golimumab effective used tnf inhibitors may equivalent effectiveness etanercept appearing injecting etanercept addition methotrexate twice week may improve decrease radiographic progression abatacept appears effective ra people improving treatment without long term safety studies yet adalimumab slows time radiographic progression used however lack evidence distinguish biologics available issues biologics include high cost association infections including use biological agents may reduce mechanism biologics reduce fatigue sodium aurothiomalate auranofin cyclosporin less commonly used due common adverse however cyclosporin found effective progressive ra used one glucocorticoids used short term lowest dose possible flareups waiting slowonset drugs take combination glucocorticoids conventional therapy shown decrease rate erosion steroids may injected affected joints initial period ra prior use dmards oral nonnsaid drugs relieve pain like paracetamol may used help relieve pain symptoms change underlying use paracetamol may associated risk developing nsaids reduce pain stiffness ra affect underlying disease appear effect peoples long term disease course thus longer first line nsaids used caution gastrointestinal cardiovascular kidney rofecoxib withdrawn global market longterm use associated increased risk heart attacks use methotrexate together nsaids safe adequate monitoring inhibitors celecoxib nsaids equally cochrane review found people preferred nsaids however yet clinically determined whether nsaids effective neuromodulator agents topical capsaicin may reasonable use attempt reduce nefopam mouth cannabis recommended risks use appear greater limited evidence suggests use weak oral opioids adverse effects may outweigh alternatively physical therapy tested shown effective aid reducing pain patients ra ra detected early treated aggressively physical therapy plays preventative compensatory role aiding pain management alongside regular rheumatic especially affected fingers hands wrists synovectomy may needed prevent pain tendon rupture drug treatment failed severely affected joints may require joint replacement surgery knee replacement postoperatively physiotherapy always insufficient evidence support surgical treatment arthritic people ra physiotherapy may used together medical may include cold heat application electronic stimulation although medications improve symptoms ra muscle function regained disease activity physiotherapy promotes physical activity ra physical activity like exercise appropriate dosage frequency intensity time type volume progression physical activity promotion effective improving cardiovascular fitness muscle strength maintaining long term active lifestyle short term resistance exercises without range motion exercises improve selfreported hand physical activity promotion according public health recommendations integral part standard care people ra arthritic additionally combination physical activities cryotherapy show efficacy disease activity pain combination aerobic activity cryotherapy may innovative therapeutic strategy improve aerobic capacity arthritis patients consequently reduce cardiovascular risk minimizing pain disease compression gloves handwear designed help prevent occurrence various medical disorders relating blood circulation wrists hands used treat symptoms though medical benefits may general enough evidence support complementary health approaches ra safety concerns mind body practices dietary supplements may help people symptoms therefore may beneficial additions conventional treatments enough evidence draw systematic review cam modalities excluding fish oil found available evidence support current use management studies showing beneficial effects ra wide variety cam modalities often affected publication bias generally high quality evidence randomized controlled trials cochrane review states low level laser therapy tried improve pain morning stiffness due rheumatoid arthritis limited evidence tai chi might improve range motion joint persons rheumatoid evidence acupuncture appearing equivalent sham cochrane review showed benefits electrical stimulation rehabilitation intervention improve power hand grip help resist may provide similar benefits dmards also highly lowquality evidence suggests use therapeutic ultrasound arthritic potential benefits include increased grip strength reduced morning stiffness number swollen tentative evidence benefit transcutaneous electrical nerve stimulation tens tens altens may decrease pain intensity improve muscle power lowquality evidence suggests people active ra may benefit assistive may include less discomfort difficulty using eye drop balance training unclear growing interest role longchain polyunsaturated fatty acids reduce inflammation alleviate symptoms ra metabolism polyunsaturated fatty acids produces docosahexaenoic acid dha eicosapentaenoic acid epa inhibits proinflammatory eicosanoids cytokines tnfa decreasing lymphocyte proliferation reactive oxygen studies showed evidence significant clinical improvements ra inflammatory status articular index gammalinolenic acid fatty acid may reduce pain tender joint count stiffness generally polyunsaturated fatty acids found fish oil flax oil hemp oil metaanalysis reported favorable effect pain although confidence effect considered moderate review reported less inflammation difference joint review examined effect marine oil fatty acids proinflammatory eicosanoid concentrations lowered people rheumatoid arthritis nonautoimmune chronic fish consumption association fourth review limited inclusion trials people eat gday three months use pain relief medication decreased improvements tender swollen joints morning stiffness physical function collectively current evidence strong enough determine supplementation fatty acids regular consumption fish effective treatments rheumatoid american college rheumatology states herbal medicines health claims supported highquality evidence thus recommend scientific basis suggest herbal supplements advertised natural safer use conventional medications chemicals herbal medications although labelled natural may toxic fatal due false belief herbal supplements always safe sometimes hesitancy report use may increase risk adverse women rheumatoid arthritis symptoms improve pregnancy might symptoms worsen methotrexate leflunomide teratogenic harmful foetus used pregnancy recommended women childbearing age use contraceptives avoid pregnancy discontinue use pregnancy low dose prednisolone hydroxychloroquine sulfasalazine considered safe pregnant women rheumatoid arthritis prednisolone used caution side effects include infections people ra increased risk infections mortality recommended vaccinations reduce inactivated influenza vaccine received pneumococcal vaccine administered twice people age lastly liveattenuated zoster vaccine administered age recommended people tumor necrosis factor alpha course disease varies greatly people mild shortterm symptoms disease progressive life around subcutaneous nodules known rheumatoid associated poor poor prognostic factors include ra reduces lifespan average three twelve young age onset long disease duration presence health problems characteristics severe ra poor functional ability overall health status lot joint damage xrays need hospitalisation involvement organs joints shown associate higher positive responses treatment may indicate better prognosis study mayo clinic noted individuals ra doubled risk heart independent risk factors diabetes excessive alcohol use elevated cholesterol blood pressure body mass index mechanism ra causes increased risk remains unknown presence chronic inflammation proposed contributing possible use new biologic drug therapies extend lifespan people ra reduce risk progression based cohort registry studies still remains hypothetical still uncertain whether biologics improve vascular function ra increase total cholesterol hdlc levels improvement atherogenic ra affects adults developed world per people newly developing condition resulted deaths onset uncommon age incidence rises age age women affected three five times often age disease commonly starts women years age men somewhat ra chronic disease although rarely spontaneous remission may occur natural course almost invariably one persistent symptoms waxing waning intensity progressive deterioration joint structures leading deformations disabilitycitation needed association periodontitis rheumatoid arthritis ra hypothesised lead enhanced generation rarelated autoantibodies oral bacteria invade blood may also contribute chronic inflammatory responses generation first recognized description ra modern medicine french physician augustin jacob landr√©beauvais based famed salp√™tri√®re hospital name rheumatoid arthritis coined british rheumatologist alfred baring art peter paul rubens may possibly depict effects ra later paintings rendered hands show opinion physicians increasing deformity consistent symptoms ra appears depicted however generally recognized art historical circles painting hands century followed certain stylized conventions clearly seen mannerist movement conventional instance show upheld right hand christ appears deformed posture conventions easily misinterpreted portrayals diseasecitation needed historic though necessarily effective treatments ra also included rest ice compression elevation apple diet nutmeg light exercise every nettles bee venom copper bracelets rhubarb diet extractions teeth fasting honey vitamins insulin magnets electroconvulsive therapy rheumatoid arthritis derived greek word ·ø•ŒµœçŒºŒ±rheuma nom ·ø•ŒµœçŒºŒ±œÑŒøœÇrheumatos gen flow current suffix oid resembling gives translation joint inflammation resembles rheumatic fever rhuma means watery discharge might refer fact joints swollen disease may made worse wet metaanalysis found association periodontal disease ra mechanism association remains two bacterial species associated periodontitis implicated mediators protein citrullination gums people vitamin deficiency common people rheumatoid arthritis general however whether vitamin deficiency cause consequence disease remains one metaanalysis found vitamin levels low people rheumatoid arthritis vitamin status correlates inversely prevalence rheumatoid arthritis suggesting vitamin deficiency associated susceptibility rheumatoid fibroblastlike synoviocytes prominent role pathogenic processes rheumatic joints therapies target cells emerging promising therapeutic tools raising hope future applications rheumatoid possible links intestinal barrier dysfunction httpsenwikipediaorgwikirheumatoidarthritis